Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

G. Chinetti,J.-C. Fruchart,B. Staels

DOI: https://doi.org/10.1007/s000110050622

IF: 6.986

2000-10-01

Inflammation Research

Abstract:Abstract: Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear receptor family. PPARs function as regulators of lipid and lipoprotein metabolism and glucose homeostasis and influence cellular proliferation, differentiation and apoptosis. PPARα is highly expressed in tissues such as liver, muscle, kidney and heart, where it stimulates the β-oxidative degradation of fatty acids. PPARγ is predominantly expressed in intestine and adipose tissue. PPARγ triggers adipocyte differentiation and promotes lipid storage. The hypolipidemic fibrates and the antidiabetic glitazones are synthetic ligands for PPARα and PPARγ, respectively. Furthermore, fatty acids and eicosanoids are natural PPAR ligands: PPARα is activated by leukotriene B4, whereas prostaglandin J2 is a PPARγ ligand. These observations suggested a potential role for PPARs not only in metabolic but also in inflammation control. The first evidence for a role of PPARα in inflammation control came from the demonstration that PPARα deficient mice display a prolonged response to inflammatory stimuli. It was suggested that PPARα deficiency results in a reduced β-oxidative degradation of these inflammatory fatty acid derivatives. More recently, PPAR activators were shown to inhibit the activation of inflammatory response genes (such as IL-2, IL-6, IL-8, TNFα and metalloproteases) by negatively interfering with the NF-κB, STAT and AP-1 signalling pathways. PPAR activators exert these anti-inflammatory activities in different immunological and vascular wall cell types such as monocyte/macrophages, endothelial, epithelial and smooth muscle cells in which PPARs are expressed. These recent findings indicate a modulatory role for PPARs in the control of the inflammatory response with potential therapeutic applications in inflammation-related diseases, such as atherosclerosis and inflammatory bowel disease.

immunology,cell biology

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the role of peroxisome proliferator - activated receptors (PPARs) in the inflammatory response and their potential therapeutic applications. Specifically:

1. **The link between PPARs in metabolism and inflammation**: The paper explores that PPARs not only play an important role in lipid metabolism and glucose homeostasis but also play a crucial role in inflammation control. This indicates that PPARs may be used as therapeutic targets for metabolic diseases and inflammation - related diseases.

2. **The anti - inflammatory mechanism of PPARs**: The paper elaborates on how PPARs exert their anti - inflammatory effects by interfering with NF - κB, STAT and AP - 1 signaling pathways to inhibit the expression of inflammatory genes (such as IL - 2, IL - 6, IL - 8, TNF - α and metalloproteinases). These effects occur in multiple immune cell and vascular wall cell types, such as monocytes/macrophages, endothelial cells, epithelial cells and smooth muscle cells.

3. **The role of PPARs in specific diseases**: The paper pays special attention to the regulatory role of PPARs in inflammation - related diseases such as atherosclerosis and inflammatory bowel disease. For example, PPARs can reduce the recruitment of monocytes to early atherosclerotic lesions, inhibit the proliferation of smooth muscle cells and reduce the production of inflammatory mediators, thereby helping to stabilize plaques and reduce the inflammatory response.

4. **The tissue distribution and regulation of PPARs**: The paper also discusses the expression patterns of PPARs in different tissues and their regulation by cytokines, which is crucial for understanding the functions of PPARs in specific tissues.

In conclusion, this paper aims to reveal the multifaceted roles of PPARs in the inflammatory response and the possibility of them being potential targets for the treatment of inflammation - related diseases.